307 related articles for article (PubMed ID: 28412735)
1. Glucose deprivation elicits phenotypic plasticity via ZEB1-mediated expression of NNMT.
Kanska J; Aspuria PP; Taylor-Harding B; Spurka L; Funari V; Orsulic S; Karlan BY; Wiedemeyer WR
Oncotarget; 2017 Apr; 8(16):26200-26220. PubMed ID: 28412735
[TBL] [Abstract][Full Text] [Related]
2. Nicotinamide N-methyltransferase overexpression may be associated with poor prognosis in ovarian cancer.
Harmankaya İ; Akar S; Uğraş S; Güler AH; Ezveci H; Aydoğdu M; Çelik Ç
J Obstet Gynaecol; 2021 Feb; 41(2):248-253. PubMed ID: 32285726
[TBL] [Abstract][Full Text] [Related]
3. Patients with low nicotinamide N-methyltransferase expression benefit significantly from bevacizumab treatment in ovarian cancer.
Li J; Yue H; Yu H; Lu X; Xue X
BMC Cancer; 2021 Jan; 21(1):67. PubMed ID: 33446144
[TBL] [Abstract][Full Text] [Related]
4. Effects of nicotinamide N-methyltransferase on PANC-1 cells proliferation, metastatic potential and survival under metabolic stress.
Yu T; Wang YT; Chen P; Li YH; Chen YX; Zeng H; Yu AM; Huang M; Bi HC
Cell Physiol Biochem; 2015; 35(2):710-21. PubMed ID: 25592232
[TBL] [Abstract][Full Text] [Related]
5. Glucose availability regulates nicotinamide N-methyltransferase expression in adipocytes.
Ehebauer F; Ghavampour S; Kraus D
Life Sci; 2020 May; 248():117474. PubMed ID: 32112869
[TBL] [Abstract][Full Text] [Related]
6. High stromal nicotinamide N-methyltransferase (NNMT) indicates poor prognosis in colorectal cancer.
Song M; Li Y; Miao M; Zhang F; Yuan H; Cao F; Chang W; Shi H; Song C
Cancer Med; 2020 Mar; 9(6):2030-2038. PubMed ID: 31989785
[TBL] [Abstract][Full Text] [Related]
7. Nicotinamide N-methyltransferase: At the crossroads between cellular metabolism and epigenetic regulation.
Roberti A; Fernández AF; Fraga MF
Mol Metab; 2021 Mar; 45():101165. PubMed ID: 33453420
[TBL] [Abstract][Full Text] [Related]
8. Nicotinamide N-methyltransferase enhances the capacity of tumorigenesis associated with the promotion of cell cycle progression in human colorectal cancer cells.
Xie X; Yu H; Wang Y; Zhou Y; Li G; Ruan Z; Li F; Wang X; Liu H; Zhang J
Arch Biochem Biophys; 2014 Dec; 564():52-66. PubMed ID: 25201588
[TBL] [Abstract][Full Text] [Related]
9. BRCA1 Deficiency Upregulates NNMT, Which Reprograms Metabolism and Sensitizes Ovarian Cancer Cells to Mitochondrial Metabolic Targeting Agents.
Kanakkanthara A; Kurmi K; Ekstrom TL; Hou X; Purfeerst ER; Heinzen EP; Correia C; Huntoon CJ; O'Brien D; Wahner Hendrickson AE; Dowdy SC; Li H; Oberg AL; Hitosugi T; Kaufmann SH; Weroha SJ; Karnitz LM
Cancer Res; 2019 Dec; 79(23):5920-5929. PubMed ID: 31619387
[TBL] [Abstract][Full Text] [Related]
10. Nicotinamide N-methyltransferase enhances chemoresistance in breast cancer through SIRT1 protein stabilization.
Wang Y; Zeng J; Wu W; Xie S; Yu H; Li G; Zhu T; Li F; Lu J; Wang GY; Xie X; Zhang J
Breast Cancer Res; 2019 May; 21(1):64. PubMed ID: 31101119
[TBL] [Abstract][Full Text] [Related]
11. Nicotinamide
Parsons RB; Facey PD
Biomolecules; 2021 Sep; 11(10):. PubMed ID: 34680055
[TBL] [Abstract][Full Text] [Related]
12. Nicotinamide N‑methyltransferase induces the proliferation and invasion of squamous cell carcinoma cells.
Hah YS; Cho HY; Jo SY; Park YS; Heo EP; Yoon TJ
Oncol Rep; 2019 Nov; 42(5):1805-1814. PubMed ID: 31545452
[TBL] [Abstract][Full Text] [Related]
13. Inhibiting proliferation in KB cancer cells by RNA interference-mediated knockdown of nicotinamide N-methyltransferase expression.
Pozzi V; Mazzotta M; Lo Muzio L; Sartini D; Santarelli A; Renzi E; Rocchetti R; Tomasetti M; Ciavarella D; Emanuelli M
Int J Immunopathol Pharmacol; 2011; 24(1):69-77. PubMed ID: 21496389
[TBL] [Abstract][Full Text] [Related]
14. Histone deacetylase inhibitor depsipeptide represses nicotinamide N-methyltransferase and hepatocyte nuclear factor-1beta gene expression in human papillary thyroid cancer cells.
Xu J; Hershman JM
Thyroid; 2006 Feb; 16(2):151-60. PubMed ID: 16676400
[TBL] [Abstract][Full Text] [Related]
15. Exosomal NNMT from peritoneum lavage fluid promotes peritoneal metastasis in gastric cancer.
Zhu AK; Shan YQ; Zhang J; Liu XC; Ying RC; Kong WC
Kaohsiung J Med Sci; 2021 Apr; 37(4):305-313. PubMed ID: 33508890
[TBL] [Abstract][Full Text] [Related]
16. Targeting nicotinamide N-methyltransferase decreased aggressiveness of osteosarcoma cells.
Serritelli EN; Sartini D; Campagna R; Pozzi V; Martin NI; van Haren MJ; Salvolini E; Cecati M; Rubini C; Emanuelli M
Eur J Clin Invest; 2024 Jun; 54(6):e14185. PubMed ID: 38426563
[TBL] [Abstract][Full Text] [Related]
17. Proteomics reveals NNMT as a master metabolic regulator of cancer-associated fibroblasts.
Eckert MA; Coscia F; Chryplewicz A; Chang JW; Hernandez KM; Pan S; Tienda SM; Nahotko DA; Li G; Blaženović I; Lastra RR; Curtis M; Yamada SD; Perets R; McGregor SM; Andrade J; Fiehn O; Moellering RE; Mann M; Lengyel E
Nature; 2019 May; 569(7758):723-728. PubMed ID: 31043742
[TBL] [Abstract][Full Text] [Related]
18. Activation of nicotinamide N-methyltransferase gene promoter by hepatocyte nuclear factor-1beta in human papillary thyroid cancer cells.
Xu J; Capezzone M; Xu X; Hershman JM
Mol Endocrinol; 2005 Feb; 19(2):527-39. PubMed ID: 15486044
[TBL] [Abstract][Full Text] [Related]
19. Hepatoblastomas exhibit marked
Rivas MP; Aguiar TFM; Maschietto M; Lemes RB; Caires-Júnior LC; Goulart E; Telles-Silva KA; Novak E; Cristofani LM; Odone V; Cypriano M; de Toledo SRC; Carraro DM; Escobar MQ; Lee H; Johnston M; da Costa CML; da Cunha IW; Tasic L; Pearson PL; Rosenberg C; Timchenko N; Krepischi ACV
Tumour Biol; 2020 Dec; 42(12):1010428320977124. PubMed ID: 33256542
[TBL] [Abstract][Full Text] [Related]
20. Nicotinamide N-methyltransferase increases complex I activity in SH-SY5Y cells via sirtuin 3.
Liu KY; Mistry RJ; Aguirre CA; Fasouli ES; Thomas MG; Klamt F; Ramsden DB; Parsons RB
Biochem Biophys Res Commun; 2015 Nov; 467(3):491-6. PubMed ID: 26456643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
